|
TTBK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68916008852693E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0513034887083E-11 |
| Normal-vs-Stage2 |
4.43880043832223E-10 |
| Normal-vs-Stage3 |
4.89053242347381E-13 |
| Normal-vs-Stage4 |
1.22346577313692E-13 |
| Stage1-vs-Stage2 |
9.890200E-01 |
| Stage1-vs-Stage3 |
1.590840E-01 |
| Stage1-vs-Stage4 |
3.384300E-02 |
| Stage2-vs-Stage3 |
3.063200E-01 |
| Stage2-vs-Stage4 |
1.361990E-01 |
| Stage3-vs-Stage4 |
5.073400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24109619750834E-12 |
| Normal-vs-AfricanAmerican |
1.31580000228837E-08 |
| Normal-vs-Asian |
5.340172748447E-12 |
| Caucasian-vs-AfricanAmerican |
6.941000E-01 |
| Caucasian-vs-Asian |
5.118400E-01 |
| AfricanAmerican-vs-Asian |
3.750800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.40438829641244E-14 |
| Normal-vs-Female |
9.11781761203656E-12 |
| Male-vs-Female |
1.725710E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.30649935314864E-11 |
| Normal-vs-Age(41-60Yrs) |
2.41906494835575E-12 |
| Normal-vs-Age(61-80Yrs) |
2.53475018752169E-12 |
| Normal-vs-Age(81-100Yrs) |
2.163800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.864400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.569000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.400800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.125400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.236200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.986600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.413980E-02 |
| Classical-VS-Follicular |
9.121200E-01 |
| Classical-VS-Other |
7.869600E-02 |
| Classical-VS-Normal |
2.34809949262171E-11 |
| Tall-VS-Follicular |
2.858000E-02 |
| Tall-VS-Other |
5.544000E-01 |
| Tall-VS-Normal |
1.75481851272252E-12 |
| Follicular-VS-Other |
2.401700E-02 |
| Follicular-VS-Normal |
1.59530166854438E-11 |
| Other-VS-Normal |
4.2147000334225E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.3101299479199E-12 |
| Normal-vs-N1 |
1.12400089236075E-11 |
| N0-vs-N1 |
6.252400E-01 |
|
|
